February 27, 2013

Genzyme Receives Company Award from European Organisation for Rare Diseases (EURORDIS)

 

Genzyme Receives Company Award from European Organisation for Rare Diseases (EURORDIS)

Paris, France – February 27, 2013 – Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today that Genzyme has received a Company Award from EURORDIS, the largest European patient organization in the field of rare diseases. The EURORDIS Company Award recognizes the outstanding accomplishments of companies dedicated to rare diseases. Genzyme was honored for pioneering the development and delivery of therapies for rare diseases, its longstanding support of patient organizations, including EURORDIS, as well as initiatives to increase patient access to Genzyme treatments.